Study Details

Additional Information

e purpose of this study is to evaluate the safety and side eects of multiple doses of the study drug in

participants with nonalcoholic fatty liver disease (NAFLD).

Covance Dallas is currently recruiting for:

• Adults, age 18-60.

• Women must be surgically sterile or postmenopausal

• BMI (body mass index) 30 and above

• Available for 3 screening visits, 1 stay of 30 overnights & up to 5 outpatient visits

• Compensation ranges from $7,370-$8,270 for time and participation

Details

Screening: Oct 20, 22, 26, 28

Check-in: Oct 22

Check-out: Nov 21

OPV: Nov 26,  Dec 4, 18, 30, Jan 15